Zenas BioPharma, Inc.
ZBIO
$16.91
-$0.02-0.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -55.55% | 36.18% | -36.26% | -1.66% | -36.61% |
| Total Depreciation and Amortization | -47.83% | -30.30% | -8.33% | 2.86% | 6.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.88% | 4.00% | 73.55% | 62.45% | 1.50% |
| Change in Net Operating Assets | 158.23% | -199.91% | 95.11% | -11.87% | -24.89% |
| Cash from Operations | -12.66% | 3.90% | -24.13% | -0.32% | -62.07% |
| Capital Expenditure | 100.00% | 75.68% | -- | 100.00% | -59.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.18% | -2,256.08% | 86.32% | -- | -- |
| Cash from Investing | -30.16% | -2,209.88% | 86.04% | -76,357.14% | -59.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,639.39% | -98.44% | -97.30% | 188,947.58% | 195.24% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -918.91% | 42.69% | -16.77% |
| Cash from Financing | 1,639.39% | -94.66% | -99.21% | 31.64% | 29,047.72% |
| Foreign Exchange rate Adjustments | -353.85% | -136.88% | 371.15% | -262.50% | -11.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.74% | -205.94% | -122.88% | 19.98% | 844.99% |